Desk›Services› Evoq Remedies Ltd
Evoq Remedies Ltd
BSE 543500 · NSE EVOQ · ISIN INE0JVD01011 · Group MT · Active
Services › Services › Commercial Services & Supplies › Trading & Distributors
₹1.69
-0.59%
BSE close, 28 August 2026
₹4.21 cr
2.5 cr shares · Micro cap
₹3.74 cr
as published
-16.9× · —
EPS ₹-0.10 · BV —
25.51 / -0.24
₹ cr, as filed
2
0 selected · 0%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -72.3% |
|---|---|
| Against 52-week low | +4.3% |
| Day change | -0.59% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹-0.10 |
|---|---|
| Price / earnings | -16.90× |
| Price / book | — |
| Book value — derived, price ÷ P/B | — |
| Return on equity | — |
| Operating margin | — |
| Net margin | — |
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Mar-26 · Q | — | -0.29 | -0.12 | — | — |
| Sep-25 · Q | 25.51 | 0.05 | 0.02 | 0.41% | 0.21% |
| FY25-26 | 25.51 | -0.24 | -0.10 | -0.78% | -0.94% |
Quarter on quarter
- Net profit, quarter on quarter
- -680.0%
Disclosure profile 2 filings in the window
| Tag | Filings |
|---|---|
| Procedural | |
| General | 1 |
| Trading Window | 1 |
| Procedural sub-total | 2 |
| Total | 2 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group MT, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
2 filings · 0 selected · busiest 2026-09-30 and 2026-10-01
Filing rhythm · the twelve most recent
2026-09-302026-10-01
SelectedProcedural
Filings
2 in the window · 2 earlier on record
-
1 October 2026 ·
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Approval Of Extension Of Time For Holding 16Th Annual General Meeting ('AGM') For The Financial Year Ended 31St March 2026
Approval of Extension of time for holding 16th Annual General Meeting for the Financial Year ended 31st March, 2026
Company Update / General View filing →
-
30 September 2026 ·
Closure of Trading Window
Intimation of Closure of Trading Window
Insider Trading / SAST / Closure of Trading Window View filing →
RSS feed for Evoq Remedies Ltd · the 50 most recent filings